Supercharge Your Innovation With Domain-Expert AI Agents!

Anti-CD22 antibody and application thereof

A technology of antibody and chimeric antigen receptor, which is applied in the field of biomedicine to achieve efficient targeting, easy preparation, and simple structure

Active Publication Date: 2022-03-08
HUADAO SHANGHAI BIOPHARMA CO LTD
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, R / R B-ALL remains clinically challenging

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-CD22 antibody and application thereof
  • Anti-CD22 antibody and application thereof
  • Anti-CD22 antibody and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0104] In this example, a phage nanobody library was constructed and panning and ELISA preliminary screening were performed.

[0105] 1. Construction of phage nanobody library

[0106] (1) Bactrian camels were immunized with CD22-Fc expressing the extracellular region, and after the titer was verified by ELISA, 200 mL of peripheral blood was drawn;

[0107] (2) Sorting lymphocytes, obtaining peripheral blood mononuclear lymphocyte precipitates, and extracting RNA;

[0108] (3) use III reverse transcriptase uses RNA as a template to synthesize the first-strand cDNA, and then uses nested PCR to amplify the VHH gene;

[0109] (4) Insert the VHH gene into the pMECS phage display vector, and after electrotransformation of TG1 competent cells, take the bacterial liquid for library identification, spread all the remaining cultures evenly on the LB / AMPGLU plate, collect the bacterial lawn after the bacterial growth, and add 1 / 3 of the volume of 50% glycerin, mixed well, stored at ...

Embodiment 2

[0118] In this example, fluorescence activated cell sorting (FACS) candidate clones were performed.

[0119] Nalm6(CD22 + ), Raji (CD22 + ), K562 (CD22 - ) (both purchased from ATCC) and SK-hep-1 (CD22 - , purchased from the Shanghai Cell Bank of the Chinese Academy of Sciences), the cells were digested with trypsin to prepare CD22-positive and negative cell suspensions, centrifuged (300×g, 5min) to remove the culture medium, and then resuspended the cells to 2×10 6 cell / mL, add 2×10 5 For the cell suspension of 1 cell, remove the supernatant after centrifugation at 300×g for 5 minutes, add the crude extract of VHH antibody to resuspend the cells, and incubate at 4°C for 1 hour, remove the supernatant after centrifugation at 300×g for 5 minutes, resuspend the cells in Flow Buffer, Dilute the APC anti-his antibody to 2 μg / mL with Flow Buffer, resuspend the cells in 100 μL per well, incubate at 4 °C for 1 h, wash the cells with Flow Buffer three times, resuspend the cells wi...

Embodiment 3

[0121] In this example, VHH-mIgG2a Fc nanobody expression, purification and antibody affinity determination were carried out.

[0122] In order to further identify the antibodies screened in Example 2, the antibodies need to be expressed in mammalian cells. Therefore, a plasmid vector C-4pCP.Stuffer-mCg2a-FC with a mouse Fc tag expressing VHH was first constructed, The build method includes the following steps:

[0123] (1) PCR amplification of CD22 VHH: CD22-28 and CD22-29, the reagents used are shown in Table 1, the primers are shown in Table 2, and the system and PCR reaction conditions are shown in Table 3;

[0124] Table 1

[0125]

[0126] Table 2

[0127]

[0128] table 3

[0129]

[0130] (2) The enzyme digestion system and reaction conditions are shown in Table 4 respectively. The PCR purification kit was used for purification, and the air-dried DNA was dissolved in 20 μL of water to detect the concentration of DNA;

[0131] Table 4

[0132]

[0133...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an anti-CD22 antibody and an application thereof. The anti-CD22 antibody comprises a heavy chain variable region, an amino acid sequence of CDR1 of the heavy chain variable region comprises a sequence as shown in SEQ ID No. 1 or SEQ ID No. 2, an amino acid sequence of CDR2 of the heavy chain variable region comprises a sequence as shown in SEQ ID No. 3 or SEQ ID No. 4, and an amino acid sequence of CDR3 of the heavy chain variable region comprises a sequence as shown in SEQ ID No. 5 or SEQ ID No. 6. The anti-CD22 antibody has high affinity and specificity and can effectively target tumor antigen CD22, the anti-CD22 antibody is used for preparing a chimeric antigen receptor and further preparing chimeric antigen recipient cells, and the chimeric antigen recipient cells can efficiently kill tumor cells and have high specificity.

Description

technical field [0001] The invention belongs to the technical field of biomedicine and relates to an anti-CD22 antibody and its application. Background technique [0002] B cell acute lymphoblastic leukemia (B-ALL) is an aggressive hematological malignancy characterized by CD19 + Clonal expansion of B cell precursors. B-ALL is one of the most common malignant tumors in children, although it is rare in adults, it has a poor prognosis. Although more than 90% of patients achieve complete remission after first-line therapy, the prognosis of patients with refractory / relapsed (R / R) B-ALL is poor. [0003] Adoptive transfer of artificial chimeric antigen receptor T cells (CAR-T) engineered to express tumor-associated antigens on the surface of cells is a revolutionary immune cell therapy for cancer. At present, CD19 CAR-T therapy is one of the ideal cell therapies for B-ALL. CD19 is uniformly expressed on malignant cells, while its off-target expression is limited to normal B ce...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/28C07K19/00C12N15/13C12N5/10C12N15/867C12N7/01A61K39/395A61K39/00A61P35/00A61P35/02
CPCC07K16/2803C07K16/005C07K14/7051C12N5/0636C12N5/0635C12N5/0646C12N5/0642C12N5/0645C12N15/86C12N7/00A61K39/001112A61K39/001113A61P35/00A61P35/02C07K2317/22C07K2317/565C07K2317/567C07K2317/569C07K2317/622C07K2317/92C07K2319/02C07K2319/03C07K2319/33C12N2510/00C12N2740/15043C12N2740/15021Y02A50/30
Inventor 狄升蒙石磊余学军
Owner HUADAO SHANGHAI BIOPHARMA CO LTD
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More